These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10233197)

  • 1. A comparative analysis of the particle size output of beclomethasone diproprionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the Babyhaler, Volumatic and Aerochamber spacer devices.
    Barry PW; O'callaghan C
    Br J Clin Pharmacol; 1999 Apr; 47(4):357-60. PubMed ID: 10233197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of large- and small-volume valved holding chambers with a new combination long-term bronchodilator/anti-inflammatory formulation delivered by pressurized metered dose inhaler.
    Nagel MW; Wiersema KJ; Bates SL; Mitchell JP
    J Aerosol Med; 2002; 15(4):427-33. PubMed ID: 12581509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol characterization of three corticosteroid metered dose inhalers with volumatic holding chambers and metered dose inhalers alone at two inspiratory flow rates.
    Terzano C; Mannino F
    J Aerosol Med; 1999; 12(4):249-54. PubMed ID: 10724639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalational drug delivery from seven different spacer devices.
    Barry PW; O'Callaghan C
    Thorax; 1996 Aug; 51(8):835-40. PubMed ID: 8795674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of aerosol drug output from the OptiChamber and AeroChamber spacers in a model system.
    Dalby RN; Somaraju S; Chavan VS; Jarvis D
    J Asthma; 1998; 35(2):173-7. PubMed ID: 9576143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus Spacer.
    Mehta R; Montembault M; Warren F; Gupta A; Brealey N; Moore A
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):386-92. PubMed ID: 26824933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
    Leach CL; Kuehl PJ; Chand R; Ketai L; Norenberg JP; McDonald JD
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro performance of three combinations of spacers and pressurized metered dose inhalers for treatment in children.
    Berg E; Madsen J; Bisgaard H
    Eur Respir J; 1998 Aug; 12(2):472-6. PubMed ID: 9727804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel breath-actuated integrated vortex spacer device increases relative lung bioavailability of fluticasone/salmeterol in combination.
    Nair A; Clearie K; Menzies D; Meldrum K; McFarlane L; Lipworth BJ
    Pulm Pharmacol Ther; 2009 Aug; 22(4):305-10. PubMed ID: 19489129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metering performance of several metered-dose inhalers with different spacers/holding chambers.
    Berlinski A; Waldrep JC
    J Aerosol Med; 2001; 14(4):427-32. PubMed ID: 11791683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of respiratory spacer devices on aerodynamic particle size distribution and fine particle mass of beclomethasone from metered-dose inhalers.
    Feddah MR; Davies NM; Gipps EM; Brown KF
    J Aerosol Med; 2001; 14(4):477-85. PubMed ID: 11791688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
    Murnane D; Martin GP; Marriott C
    Pharm Res; 2008 Oct; 25(10):2283-91. PubMed ID: 18509598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The output of budesonide from spacer devices assessed under simulated breathing conditions.
    Barry PW; O'Callaghan C
    J Allergy Clin Immunol; 1999 Dec; 104(6):1205-10. PubMed ID: 10589002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of particle size distribution of salmeterol administered via metered-dose inhaler with and without valved holding chambers.
    Kelly HW; Ahrens RC; Holmes M; Stevens AL; Vandermeer AK; Garris T; Reisner C
    Ann Allergy Asthma Immunol; 2001 Dec; 87(6):482-7. PubMed ID: 11770695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices.
    Lipworth BJ; Clark DJ
    Br J Clin Pharmacol; 1998 Jul; 46(1):45-8. PubMed ID: 9690948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
    Edin HM; Andersen LB; Schoaf L; Scott-Wilson CA; Ho SY; Ortega HG
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pulmonary function and pharmacokinetics of fluticasone propionate and salmeterol xinafoate delivered by two dry powder inhalers to patients with asthma.
    Harrison LI; Novak CC; Needham MJ; Ratner P
    J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):245-52. PubMed ID: 21671752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
    Leach CL; Colice GL
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emitted doses of salbutamol pressurized metered-dose inhaler from five different plastic spacer devices.
    Dubus JC; Dolovich M
    Fundam Clin Pharmacol; 2000; 14(3):219-24. PubMed ID: 15602798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study.
    Corda L; Gardenghi GG; Modina D; Montemurro LT; Novali M; Tantucci C
    Allergy Asthma Proc; 2011; 32(6):29-34. PubMed ID: 22221427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.